Headache? Toothache? Is Haleon’s OTC portfolio immune from attack?
Haleon is the spin off of GSK’s OTC (over the counter medicine) business. This month it was reborn as a stand-alone company independently listed on the London stock exchange. Haleon has a market valuation of £30.5b (US$36.2b) and a portfolio of brands including Sensodyne (oral care) and Panadol (pain relief). The company makes 63% gross …
Headache? Toothache? Is Haleon’s OTC portfolio immune from attack? Read More »